Treatment for Diabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
DiabetesTreatment - DietarySupplement
Eligibility
45 - 75
All Sexes
What conditions do you have?
Select

Study Summary

This trial will see if NMN can help improve metabolism in people, as it has been shown to in rodents.

Eligible Conditions
  • Diabetes

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: before and after at least 16 weeks of treatment

Week 16
Change in Muscle insulin sensitivity
Changes in glucose tolerance

Trial Safety

Trial Design

2 Treatment Groups

NMN supplementation
1 of 2
Placebo
1 of 2

Experimental Treatment

Non-Treatment Group

56 Total Participants · 2 Treatment Groups

Primary Treatment: Treatment · Has Placebo Group · N/A

NMN supplementation
DietarySupplement
Experimental Group · 1 Intervention: Treatment · Intervention Types: DietarySupplement
Placebo
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Treatment
2013
Completed Phase 3
~13700

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: before and after at least 16 weeks of treatment

Who is running the clinical trial?

United States Department of DefenseFED
778 Previous Clinical Trials
202,466 Total Patients Enrolled
3 Trials studying Diabetes
311 Patients Enrolled for Diabetes
Washington University School of MedicineLead Sponsor
1,803 Previous Clinical Trials
2,279,393 Total Patients Enrolled
17 Trials studying Diabetes
5,607 Patients Enrolled for Diabetes
Samuel Klein, MDPrincipal InvestigatorWashington University School of Medicine
26 Previous Clinical Trials
2,131 Total Patients Enrolled
1 Trials studying Diabetes
101 Patients Enrolled for Diabetes

Eligibility Criteria

Age 45 - 75 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: